![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:ANGPTL4-CLCN3 (FusionGDB2 ID:HG51129TG1182) |
Fusion Gene Summary for ANGPTL4-CLCN3 |
![]() |
Fusion gene information | Fusion gene name: ANGPTL4-CLCN3 | Fusion gene ID: hg51129tg1182 | Hgene | Tgene | Gene symbol | ANGPTL4 | CLCN3 | Gene ID | 51129 | 1182 |
Gene name | angiopoietin like 4 | chloride voltage-gated channel 3 | |
Synonyms | ARP4|FIAF|HARP|HFARP|NL2|PGAR|TGQTL|UNQ171|pp1158 | CLC3|ClC-3 | |
Cytomap | ('ANGPTL4')('CLCN3') 19p13.2 | 4q33 | |
Type of gene | protein-coding | protein-coding | |
Description | angiopoietin-related protein 4PPARG angiopoietin related proteinfasting-induced adipose factorhepatic angiopoietin-related proteinhepatic fibrinogen/angiopoietin-related proteinperoxisome proliferator-activated receptor (PPAR) gamma induced angiopoie | H(+)/Cl(-) exchange transporter 3chloride channel 3chloride channel protein 3chloride channel, voltage-sensitive 3chloride transporter ClC-3 | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | . | P51790 | |
Ensembl transtripts involved in fusion gene | ENST00000301455, ENST00000393962, ENST00000541807, | ||
Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 37 X 5 X 19=3515 |
# samples | 3 | 37 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(37/3515*10)=-3.24792751344359 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ANGPTL4 [Title/Abstract] AND CLCN3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ANGPTL4(8439257)-CLCN3(170623929), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ANGPTL4 | GO:0043066 | negative regulation of apoptotic process | 10698685 |
Hgene | ANGPTL4 | GO:0043335 | protein unfolding | 29899144 |
Hgene | ANGPTL4 | GO:0051005 | negative regulation of lipoprotein lipase activity | 19542565|29899144 |
Tgene | CLCN3 | GO:1902476 | chloride transmembrane transport | 11274166 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUAD | TCGA-80-5608-01A | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
Top |
Fusion Gene ORF analysis for ANGPTL4-CLCN3 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000301455 | ENST00000347613 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
5CDS-intron | ENST00000301455 | ENST00000360642 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
5CDS-intron | ENST00000301455 | ENST00000504131 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
5CDS-intron | ENST00000301455 | ENST00000506924 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
5CDS-intron | ENST00000301455 | ENST00000513761 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000393962 | ENST00000347613 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000393962 | ENST00000360642 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000393962 | ENST00000504131 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000393962 | ENST00000506924 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000393962 | ENST00000513761 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000541807 | ENST00000347613 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000541807 | ENST00000360642 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000541807 | ENST00000504131 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000541807 | ENST00000506924 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
intron-intron | ENST00000541807 | ENST00000513761 | ANGPTL4 | chr19 | 8439257 | - | CLCN3 | chr4 | 170623929 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ANGPTL4-CLCN3 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for ANGPTL4-CLCN3 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:8439257/:170623929) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | CLCN3 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: [Isoform 1]: Strongly outwardly rectifying, electrogenic H(+)/Cl(-)exchanger which mediates the exchange of chloride ions against protons (By similarity). The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (PubMed:29845874). The presence of conserved gating glutamate residues is typical for family members that function as antiporters (PubMed:29845874). {ECO:0000250|UniProtKB:P51791, ECO:0000303|PubMed:29845874}.; FUNCTION: [Isoform 2]: Strongly outwardly rectifying, electrogenic H(+)/Cl(-)exchanger which mediates the exchange of chloride ions against protons. {ECO:0000269|PubMed:11967229}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ANGPTL4-CLCN3 |
![]() |
Top |
Fusion Gene PPI Analysis for ANGPTL4-CLCN3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ANGPTL4-CLCN3 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ANGPTL4-CLCN3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ANGPTL4 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Hgene | ANGPTL4 | C0007097 | Carcinoma | 1 | CTD_human |
Hgene | ANGPTL4 | C0010054 | Coronary Arteriosclerosis | 1 | CTD_human |
Hgene | ANGPTL4 | C0015695 | Fatty Liver | 1 | CTD_human |
Hgene | ANGPTL4 | C0020557 | Hypertriglyceridemia | 1 | CTD_human |
Hgene | ANGPTL4 | C0024232 | Lymphatic Metastasis | 1 | CTD_human |
Hgene | ANGPTL4 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | ANGPTL4 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Hgene | ANGPTL4 | C0028754 | Obesity | 1 | CTD_human |
Hgene | ANGPTL4 | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Hgene | ANGPTL4 | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Hgene | ANGPTL4 | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Hgene | ANGPTL4 | C0205699 | Carcinomatosis | 1 | CTD_human |
Hgene | ANGPTL4 | C0242339 | Dyslipidemias | 1 | CTD_human |
Hgene | ANGPTL4 | C0598784 | Dyslipoproteinemias | 1 | CTD_human |
Hgene | ANGPTL4 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Hgene | ANGPTL4 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Hgene | ANGPTL4 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | ANGPTL4 | C1956346 | Coronary Artery Disease | 1 | CTD_human |
Hgene | ANGPTL4 | C2711227 | Steatohepatitis | 1 | CTD_human |
Hgene | ANGPTL4 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Tgene | C0017638 | Glioma | 1 | CTD_human | |
Tgene | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human | |
Tgene | C0038356 | Stomach Neoplasms | 1 | CTD_human | |
Tgene | C0235874 | Disease Exacerbation | 1 | CTD_human | |
Tgene | C0259783 | mixed gliomas | 1 | CTD_human | |
Tgene | C0555198 | Malignant Glioma | 1 | CTD_human | |
Tgene | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human | |
Tgene | C2931822 | Nasopharyngeal carcinoma | 1 | CTD_human |